KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teradyne (TER) Cost of Revenue: 2009-2025

Historic Cost of Revenue for Teradyne (TER) over the last 17 years, with Q3 2025 value amounting to $319.9 million.

  • Teradyne's Cost of Revenue rose 635.67% to $319.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year increase of 157.54%. This contributed to the annual value of $1.2 billion for FY2024, which is 275.57% up from last year.
  • Per Teradyne's latest filing, its Cost of Revenue stood at $319.9 million for Q3 2025, which was up 635.67% from $278.8 million recorded in Q2 2025.
  • Teradyne's 5-year Cost of Revenue high stood at $438.7 million for Q3 2021, and its period low was $260.5 million during Q1 2024.
  • For the 5-year period, Teradyne's Cost of Revenue averaged around $313.9 million, with its median value being $305.4 million (2023).
  • Its Cost of Revenue has fluctuated over the past 5 years, first skyrocketed by 1948.62% in 2021, then plummeted by 2378.68% in 2022.
  • Teradyne's Cost of Revenue (Quarter) stood at $358.0 million in 2021, then fell by 13.02% to $311.4 million in 2022, then decreased by 6.53% to $291.1 million in 2023, then rose by 5.0% to $305.6 million in 2024, then grew by 4.68% to $319.9 million in 2025.
  • Its Cost of Revenue stands at $319.9 million for Q3 2025, versus $278.8 million for Q2 2025 and $270.3 million for Q1 2025.